AI Summary

The bill aims to expand health insurance coverage for biomarker testing, which helps in diagnosing and treating diseases like cancer. It requires insurance plans to cover these tests without cost-sharing requirements for patients. This legislation seeks to improve access to precision medicine and personalized treatments by ensuring that individuals can undergo biomarker testing without financial barriers.

• 2023-01-19: First reading, referred to Health Care & Wellness.

• 2023-01-31: Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.

• 2023-02-08: Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.

• 2023-02-08: HCW - Majority; 1st substitute bill be substituted, do pass.

• 2023-02-08: Minority; do not pass.

• 2023-02-10: Referred to Appropriations.

• 2024-01-08: By resolution, reintroduced and retained in present status.

• 2024-01-18: Committee relieved of further consideration.

• 2024-01-18: Referred to Health Care & Wellness.

• 2024-01-26: Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.

• 2024-01-30: Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.

• 2024-01-30: HCW - Majority; 2nd substitute bill be substituted, do pass.

• 2024-01-31: Referred to Appropriations.